Severe Hypersensitivity: Severe hypersensitivity reactions, including anaphylaxis and anaphylactic shock, can occur in patients treated with PIQRAY. PIQRAY is contraindicated in patients with severe hypersensitivity to it or any of its components. PIQRAY® (alpelisib) 50mg, 150mg, 200mg tablets is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen. Scheduled the specimen pickup (priority overnight) with the carrierįor additional shipping instructions, including plasma specimen labeling and packaging, call NeoGenomics Client Services at 1-86.
Shipping kit (DeepFreeze™ Shipper by NanoCool) Please ensure that you have the following items prior to initiation of plasma shipment: To request the kit, please contact NeoGenomics Client Services at 1-86. DeepFreeze™ insulated shippers are qualified to ship on dry ice for up to 96 hours without re-icing. If you are utilizing NeoGenomics, plasma will be shipped to NeoGenomics priority overnight using a DeepFreeze™ Shipper by NanoCool. Failure to do so may result in test failure. Whole blood collected in K 2EDTA blood collection tubes must be processed to separate plasma within 4 hours of blood collection. To send plasma specimen to NeoGenomics for testing, you must have the following 3:Ī centrifuge with 4☌ setting to spin down blood and separate plasmaĪ specimen freezer that can store the specimen at -80☌ after plasma separation (-70☌ to -90☌ is acceptable)ĭry ice to use when transporting the specimen to NeoGenomics for testingĬalled NeoGenomics Client Services for requisition form and supplies Following prequalification by NeoGenomics, you will need to complete the NeoGenomics PIK3CA Mutation CDx Plasma Test Request Form and include a copy of the patient’s pathology report.